Cell Therapy Market Size Worth USD 21.69 Billion in 2032 | Emergen Research

The global cell therapy market size was USD 4.77 Billion in 2022 and is expected to register a rapid revenue CAGR of 16.3% during the forecast period. The global cell therapy market is experiencing substantial growth, driven by an increase in cell therapy clinical studies, a surge in chronic conditions, and technological advancements in regenerative medicine. These findings are detailed in a comprehensive market research report recently published.

Cell-based therapies offer promising potential to replace, repair, restore, or regenerate damaged tissues and organs, attracting significant research funding worldwide. Oncology leads in T cell studies, while mesenchymal stem/stromal cells are predominantly used in clinical research.

Click To get SAMPLE PDF (Including Full TOC, Graphs & Charts, Table & Figures)@ https://www.emergenresearch.com/request-sample/2549

Key Drivers:

• Increasing prevalence of chronic conditions, particularly cancer.

• Regulatory initiatives promoting advanced therapy development.

• Technological advancements, including direct cellular reprogramming.

Notable Developments:

• Bayer AG inaugurated its Cell Therapy Launch Facility in California to advance cell medicines.

• Cedars-Sinai received funding to establish a groundbreaking clinic for stem cell research.

• Bristol Myers Squibb obtained FDA approval for Breyanzi for lymphoma treatment.

• Omisirge received FDA licensure for allogeneic cord blood-based cell treatment.

Market Restraints:

• Ethical concerns with stem cell research.

• Clinical challenges and high costs associated with cell therapy.

• Strict regulatory guidelines.

Segment Insights: 1. Cell Type:

• Stem cells account for the largest revenue share due to their versatility and clinical implications.

• T Cells segment is expected to register moderate growth due to increasing chronic diseases.

2. Therapy Type:

• Autologous segment dominates due to advantages like easy availability and lower risk of complications.

• Allogenic segment shows steady growth due to rising demand for stem cell transplantation.

3. Application:

• Oncology segment is expected to grow fastest, driven by increasing cancer prevalence.

• Musculoskeletal disorders segment holds the largest revenue share due to ongoing research in tissue regeneration.

Get An Impressive Discount On This Report@ https://www.emergenresearch.com/request-discount/2549

Cell Therapy Top Companies and Competitive Landscape

The global cell therapy market is fragmented, with many medium and large-sized players accounting for majority of market revenue. Major players are deploying various strategies, entering into mergers & acquisitions, strategic agreements & contracts, developing, testing, and introducing novel cell therapies.

Some major players included in the global cell therapy market report are:

• JCR Pharmaceuticals Co., Ltd.
• NuVasive, Inc.
• Kolon TissueGene, Inc.
• Mesoblast Ltd.
• Medipost Co.
• Stemedica Cell Technologies, Inc.
• Novartis AG
• Gilead Sciences, Inc.
• Tegoscience
• Atara Biotherapeutics, Inc.
• Takeda Pharmaceutical Company Limited
• bluebird bio, Inc.
• Dendreon Pharmaceuticals LLC.
• Thermo Fisher Scientific Inc.
• Becton, Dickinson, and Company
• Lonza
• Sartorius AG
• Castle Creek Biosciences, Inc.
• Anterogen Co., Ltd.
• Celgene Corporation

Cell Therapy Latest Industry News

• In December 2022, Kite, a Gilead Company, and Arcellx, Inc. announced a global strategic collaboration to co-develop and co-commercialize CART-ddBCMA, Arcellx's flagship late-stage product candidate for the treatment of relapsed or refractory multiple myeloma. CART-ddBCMA is an experimental cell treatment product in Phase 2 clinical development that consists of autologous T cells that have been genetically engineered to target multiple myeloma.

• In January 2022, Cellino Biotech, a cell treatment manufacturing company recently secured USD 80 million in a Series A investment round. By 2025, the company will develop the world's first autonomous human cell foundry. The aim of this project is to make stem cell-based medical therapies more widely available, potentially enhancing the field of regenerative medicine.

Buy the full research report at @
https://www.emergenresearch.com/select-license/2549

Cell Therapy Market Segment Analysis

For the purpose of this report, Emergen research has segmented the global cell therapy market on the basis of cell type, therapy type, technology, application, end-use, and region:

• Cell Type Outlook (Revenue, USD Billion; 2019-2032)
o Stem Cell
o T Cells
o Others
• Therapy Type Outlook (Revenue, USD Billion; 2019-2032)
o Autologous
o Allogeneic
• Technology Outlook (Revenue, USD Billion; 2019-2032)
o Viral Vector Technology
o Genome Editing Technology
o Somatic Cell Technology
o Cell Immortalization Technology
o Cell Plasticity Technology
o Three-dimensional Technology
• Application Outlook (Revenue, USD Billion; 2019-2032)
o Oncology
o Musculoskeletal Disorder
o Autoimmune Disorders
o Dermatology
o Cardiovascular
o Ocular
o Others
• End-use Outlook (Revenue, USD Billion; 2019-2032)
o Hospitals & Clinics
o Biopharmaceutical and Biotechnology Companies
o Contract Research Organizations (CROs)/Contract Manufacturing Organizations (CMOs)
o Regenerative Medicine Centers
o Others
• Regional Outlook (Revenue, USD Billion; 2019-2032)
o North America
1. U.S.
2. Canada
3. Mexico
o Europe
1. Germany
2. France
3. UK
4. Italy
5. Spain
6. Benelux
7. Rest of Europe
o Asia Pacific
1. China
2. India
3. Japan
4. South Korea
5. Rest of APAC
o Latin America
1. Brazil
2. Rest of LATAM
o Middle East & Africa
1. Saudi Arabia
2. UAE
3. South Africa
4. Turkey
5. Rest of Middle East & Africa

Acquire the complete research report on the Global Market@ https://www.emergenresearch.com/industry-report/cell-therapy-market

Look Over transcripts provided by Emergen Research

Interventional Oncology Devices Market
https://www.emergenresearch.com/jp/industry-report/インターベンショナル-腫瘍学-デバイス-市場
Liquid Hydrogen Market
https://www.emergenresearch.com/jp/industry-report/液体-水素-市場
Simultaneous Localization and Mapping (SLAM) Technology Market
https://www.emergenresearch.com/jp/industry-report/slam-技術-市場
Electric Commercial Vehicle Market
https://www.emergenresearch.com/jp/industry-report/電気-商業-自動車-市場

Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights

About Us:
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

This release was published on openPR.